chartexchange

Merck and Isomorphic Labs Enter Strategic Research Collaboration

Business Wire | Nov 19, 2026 6:45 AM EST

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Isomorphic Labs, an AI-first drug design and development company, today announced a research collaboration that brings together Isomorphic Labs’ AI approach to drug discovery with Merck’s rich proprietary data resources and deep discovery experience. The companies will collaborate to discover therapeutic small molecule candidates against an oncology target of strategic importance. Isomorp

Read original article